Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genomic Driven Chemotherapy vs Standard Neoadjuvant Chemotherapy in Breast Cancer
NCT01180335Phase 3Completed
- Sponsor
- Gustave Roussy
- Start
- Jan 2009
- Primary completion
- Dec 2010
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Paclitaxel Micelles for Injection, fluorouracil, epirubicin, cyclophosphamide, docetaxel in breast cancer, sponsored by Gustave Roussy. Started Jan 2009; status: completed.
02
Drugs
Paclitaxel Micelles for Injectionfluorouracilepirubicincyclophosphamidedocetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01180335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01180335.